Robust freeze-drying process re-design of a legacy product based on risk analysis and design of experiments

References

• Yu LX, Amidon G, Khan MA, et al. Understanding pharmaceutical quality by design. AAPS J. 2014;16(4):771–783.
   PubMed Web of Science ®Google Scholar
• Tabora JE, Domagalski N. Multivariate analysis and statistics in pharmaceutical process research and development. Annu Rev Chem Biomol Eng. 2017;8:403–426.
   PubMed Web of Science ®Google Scholar
• Garcia T, Cook G, Nosal R. PQLI key topics - criticality, design space, and control strategy. J Pharm Innov. 2008;3(2):60–68.
   Google Scholar
• Mockus LN, Paul TW, Pease NA, et al. Quality by design in formulation and process development for a freeze-dried, small molecule parenteral product: a case study. Pharm Dev Technol. 2011;16(6):549–576.
   PubMed Web of Science ®Google Scholar
• Awotwe-Otoo D, Agarabi C, Wu GK, et al. Quality by design: impact of formulation variables and their interactions on quality attributes of a lyophilized monoclonal antibody. Int J Pharm. 2012;438(1–2):167–175.
   PubMedGoogle Scholar
• Sylvester B, Porfire A, Achim M, et al. A step forward towards the development of stable freeze-dried liposomes: a quality by design approach (QbD). Drug Dev Ind Pharm. 2018;44(3):385–397.
   PubMed Web of Science ®Google Scholar
• Casian T, Iurian S, Bogdan C, et al. QbD for pediatric oral lyophilisates development: risk assessment followed by screening and optimization. Drug Dev Ind Pharm. 2017;43(12):1932–1944.
   PubMed Web of Science ®Google Scholar
• Tang X, Pikal MJ. Design of freeze-drying processes for pharmaceuticals: practical advice. Pharm Res. 2004;21(2):191–200.
   PubMed Web of Science ®Google Scholar
• US Food and Drug Administration. Inspection guides - lyophilization of parenteral (7/93); 2014 Nov 11 [cited 2020 April 27]. Available from: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/inspection-guides/lyophilization-parenteral-793
   Google Scholar
• Patel A, Erb SM, Strange L, et al. Combined semi-empirical screening and design of experiments (DOE) approach to identify candidate formulations of a lyophilized live attenuated tetravalent viral vaccine candidate. Vaccine. 2018;36(22):3169–3179.
   PubMed Web of Science ®Google Scholar
• Liu D, Galvanin F, Yu Y. Formulation screening and freeze-drying process optimization of Ginkgolide B lyophilized powder for injection. AAPS PharmSciTech. 2018;19(2):541–550.
   PubMed Web of Science ®Google Scholar
• Goldman JM, More HT, Yee O, et al. Optimization of primary drying in lyophilization during early-phase drug development using a definitive screening design with formulation and process factors. J Pharm Sci. 2018;107(10):2592–2600.
   PubMed Web of Science ®Google Scholar
• Kawasaki H, Shimanouchi T, Kimura Y. Recent development of optimization of lyophilization process. J Chem. 2019;2019(9502856):1–14.
   Google Scholar
• Fissore D, Pisano R, Barresi AA. Process analytical technology for monitoring pharmaceuticals freeze-drying–a comprehensive review. Dry Technol. 2018;36(15):1839–1865.
   Web of Science ®Google Scholar
• Pisano R, Fissore D, Barresi AA, et al. Quality by design: optimization of a freeze-drying cycle via design space in case of heterogeneous drying behavior and influence of the freezing protocol. Pharm Dev Technol. 2013;18(1):280–295.
   PubMed Web of Science ®Google Scholar
• Pisano R, Fissore D, Barresi AA, et al. Quality by design: scale-up of freeze-drying cycles in pharmaceutical industry. AAPS PharmSciTech. 2013;14(3):1137–1149.
   PubMed Web of Science ®Google Scholar
• Fissore D, Pisano R, Barresi AA. Model-based framework for the analysis of failure consequences in a freeze-drying process. Ind Eng Chem Res. 2012;51(38):12386–12397.
   Web of Science ®Google Scholar
• Arsiccio A, Pisano R. Application of the quality by design approach to the freezing step of freeze-drying: building the design space. J Pharm Sci. 2018;107(6):1586–1596.
   PubMed Web of Science ®Google Scholar
• Nikolic S. Quality by redesign of a legacy product case study. Pharma Eng. 2019. Available from: https://ispe.org/pharmaceutical-engineering/march-april-2019/quality-redesign-legacy-product-case-study
   Google Scholar
• Clua-Palau G, Jo E, Nikolic S, et al. Finding a reliable limit of detection in the NIR determination of residual moisture in a freeze-dried drug product. J Pharm Biomed Anal. 2020;183:113163.
   PubMed Web of Science ®Google Scholar
• Patel SM, Jameel F, Sane SU, et al. Lyophilization process design and development using QbD principles. In: Jameel F, Hershenson S, Khan MA, Martin-Moe S, editors. Quality by design for biopharmaceutical drug product development. New York (NY): Springer; 2015. p. 303–329.
   Google Scholar
• Doehlert DH. Uniform shell designs. Appl Stat. 1970;19(3):231–239.
   Web of Science ®Google Scholar
• Eriksson L, Johansson E, Kettaneh-Wold N, et al. Design of experiments: principles and applications. 3rd ed. Umea (Sweden): MKS Umetrics AB; 2008.
   Google Scholar
• Patel SM, Nail SL, Pikal MJ, et al. Lyophilized drug product cake appearance: what is acceptable? J Pharm Sci. 2017;106(7):1706–1721.
   PubMed Web of Science ®Google Scholar
• Jameel F, Searles J. Development and optimization of the freeze-drying processes. In: Jameel F, Hershenson S, editors. Formulation and process development strategies for manufacturing biopharmaceuticals. Hoboken (NJ): John Wiley & Sons, Inc.; 2010. p. 763–796.
   Google Scholar
• Xiang J, Hey JM, Liedtke V, et al. Investigation of freeze-drying sublimation rates using a freeze-drying microbalance technique. Int J Pharm. 2004;279(1–2):95–105.
   PubMedGoogle Scholar
• Trappler E. Strategies in development of lyophilized parenterals. Am Pharm Rev. 2003;5:54–58.
   Google Scholar
• Franco M, Assegehegn G, Fuente EB, et al. An experimental-based approach to construct the process design space of a freeze-drying process: an effective tool to design an optimum and robust freeze-drying process for pharmaceuticals. J Pharm Sci. 2020;109(1):785–796.
   PubMed Web of Science ®Google Scholar